Gene Logic Signs Agreement with GE Healthcare to Distribute New Gene Expression Analysis System to Academic, Government and Othe

Gene Logic Inc. (NASDAQ:GLGC) announced today it has
signed an agreement with GE Healthcare for global distribution of Gene
Logic's new SCIANTIS(TM) System, an online gene expression analysis
system developed for use by academic, government and other non-profit
research organizations. GE Healthcare will distribute the system in 32
countries and will be the exclusive distributor in Japan. Financial
details of the agreement were not disclosed.
   The SCIANTIS System is user friendly, browser based, and designed
to help researchers quickly and easily profile the expression of
human, rat and mouse genes in normal and diseased tissues in order to
better understand the relationship of gene expression to biological
function and mechanisms of disease. The system is based on Gene
Logic's gene expression reference database, which allows accurate
expression comparisons due to the Company's industry-leading quality
control metrics and sample processing automation, which are employed
at its state-of-the-art facility. The SCIANTIS System features:

   --  Gene expression profiles from more than 6,000 human, rat, and
        mouse tissue samples curated by expert pathologists into more
        than 800 sample sets.

   --  Summary expression data for more than 30,000 genes in each
        sample set.

   --  Proprietary software that allows researchers to quickly
        visualize data of interest and generate reports regarding gene
        expression across a wide variety of cell lines or tissues.

   --  Data segmented into five disease areas, including
        inflammation, cardiovascular disease, oncology, central
        nervous system disorders, and metabolic diseases.

   Dennis Rossi, senior vice president and general manager, Genomics
for Gene Logic, said, "We designed the SCIANTIS System for the
thousands of academic and university researchers who have not had
access to the same gene expression analysis systems as their industry
counterparts. We have coupled this new product with GE Healthcare's
strong brand and powerful worldwide marketing and sales capabilities.
We are positioned to significantly broaden our customer base in
alliance with one of the largest and best-known corporations in the
world, through GE Healthcare's innovative marketing, web commerce,
direct selling and broad distributor network."
   Ger Brophy, head of product acquisition and licensing, GE
Healthcare said, "We are excited to work with Gene Logic, a leader in
genomics services, to distribute the SCIANTIS System, an innovative
and effective way for researchers to more efficiently analyze genetic
expression data. The SCIANTIS System is a valuable addition to the
technologies and services GE Healthcare offers to our life sciences
customers."

   Gene Logic Overview

   Gene Logic aspires to be the most valued drug development
solutions partner to the pharmaceutical industry. Gene Logic applies
its broad and unique mix of technologies, talent and methodologies to
work on behalf of its partners to enable pharmaceutical and
biotechnology companies to make more informed, more reliable and more
predictive decisions at each point in the highly complex and costly
drug development process. For more information, visit
www.genelogic.com or call toll-free - 1/800/GENELOGIC.

   About GE Healthcare

   GE Healthcare provides transformational medical technologies that
will shape a new age of patient care. GE Healthcare's expertise in
medical imaging and information technologies, medical diagnostics,
patient monitoring systems, disease research, drug discovery and
biopharmaceutical manufacturing technologies is dedicated to detecting
disease earlier and helping physicians tailor treatment for individual
patients. GE Healthcare offers a broad range of services to improve
productivity in healthcare and enable healthcare providers to better
diagnose, treat and manage patients with conditions such as cancer,
neurological and cardiovascular diseases.
   GE Healthcare is a $14 billion unit of General Electric Company
(NYSE: GE) that is headquartered in the United Kingdom. Worldwide, GE
Healthcare employs more than 42,500 people committed to serving
healthcare professionals and their patients in more than 100
countries. For more information about GE Healthcare, visit our website
at: www.gehealthcare.com.